FDA Okays Imaging Agent (Netspot) for Neuroendocrine TumorsFDA Okays Imaging Agent (Netspot) for Neuroendocrine Tumors

The product is the first kit for the preparation of gallium Ga 68 dotatate injection, a PET imaging agent used to detect somatostatin receptor-positive neuroendocrine tumors. FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news